Private investment company Broadlake achieved a three-times-plus return on its capital from the estimated $30 million (€25 million) sale last week of Vita Liberata, the Northern Ireland-headquartered skincare and self-tan brand, to US-based Crown Laboratories.
Broadlake, which is led by Pete Smyth, has exited businesses worth over €100 million since November after the recent sale of shower enclosures maker Merlyn Industries for over €68 million. The Dublin-based fund made a four-times return on its investment in...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team